Human coronaviruses 229E and NL63: Close yet still so far

Journal of the Formosan Medical Association

Volumn 108, Issue 4, 2009, Pages 270-279

  Dijkman, Ronald ^a   van der Hoek, Lia ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Common cold; Croup; Human coronavirus 229E; Human coronavirus NL63

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; IMMUNOGLOBULIN; PROTEINASE INHIBITOR;

AUTOIMMUNE DISEASE; COMMON COLD; CORONAVIRUS; CROUP; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; GENETIC VARIABILITY; HUMAN; MOLECULAR EVOLUTION; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTIPLE SCLEROSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PHYLOGENY; PREVALENCE; RESPIRATORY TRACT DISEASE; REVIEW; RHINORRHEA; SEVERE ACUTE RESPIRATORY SYNDROME; TRANSMISSIBLE GASTROENTERITIS VIRUS; VIRUS GENOME; VIRUS INFECTION; VIRUS ISOLATION; VIRUS REPLICATION;

EID: 65549116858     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0929-6646(09)60066-8     Document Type: Review

References (93)

1. Lai MMC, Perlman S, Anderson JL. Coronaviridae. In: Knipe DM, Howley PM, eds. Fields Virology, 5th edition. Philadelphia: Lippincott Williams & Wilkins, 2006:1305-35.
2. Hamre D, Procknow JJ. A new virus isolated from the human respiratory tract. Proc Soc Exp Biol Med 1966;121:190-3.
3. McIntosh K, Dees JH, Becker WB, et al. Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc Natl Acad Sci USA 1967;57:933-40.
4. Rota PA, Oberste MS, Monroe SS, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003;300:1394-9.
5. Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967-76.
6. van der Hoek L, Pyrc K, Jebbink MF, et al. Identification of a new human coronavirus. Nat Med 2004;10:368-73.
7. Woo PC, Lau SK, Huang Y, et al. Phylogenetic and recombination analysis of coronavirus HKU1, a novel coronavirus from patients with pneumonia. Arch Virol 2005;150: 2299-311.
8. van der Hoek L. Human coronaviruses: what do they cause? Antivir Ther 2007;12:651-8.
9. Li W, Shi Z, Yu M, et al. Bats are natural reservoirs of SARS-like coronaviruses. Science 2005;310:676-9.
10. Tang XC, Zhang JX, Zhang SY, et al. Prevalence and genetic diversity of coronaviruses in bats from China. J Virol 2006;80:7481-90.
11. Zhang J, Guy JS, Snijder EJ, et al. Genomic characterization of equine coronavirus. Virol 2007;369:92-104.
12. Woo PC, Wang M, Lau SK, et al. Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features. J Virol 2007;81:1574-85.
13. Dong BQ, Liu W, Fan XH, et al. Detection of a novel and highly divergent coronavirus from Asian leopard cats and Chinese ferret badgers in Southern China. J Virol 2007;81: 6920-6.
14. Lau SK, Woo PC, Li KS, et al. Complete genome sequence of bat coronavirus HKU2 from Chinese horseshoe bats revealed a much smaller spike gene with a different evolutionary lineage from the rest of the genome. Virology 2007;367:428-39.
15. Mihindukulasuriya KA, Wu G, St Leger J, et al. Identification of a novel coronavirus from a beluga whale by using a panviral microarray. J Virol 2008;82:5084-8.
16. Chu DK, Peiris JS, Chen H, et al. Genomic characterizations of bat coronaviruses (1A, 1B and HKU8) and evidence for co-infections in Miniopterus bats. J Gen Virol 2008;89:1282-7.
17. Larkin MA, Blackshields G, Brown NP, et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007;23:2947-8.
18. Tamura K, Dudley J, Nei M, et al. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24:1596-9.
19. Wang LF, Eaton BT. Bats, civets and the emergence of SARS. Curr Top Microbiol Immunol 2007;315:325-44.
20. Doyle LP, Hutchings LM. A transmissible gastroenteritis in pigs. J Am Vet Med Assoc 1946;108:257-9.
21. Almeida JD, Tyrrell DA. The morphology of three previously uncharacterized human respiratory viruses that grow in organ culture. J Gen Virol 1967;1:175-8.
22. Binn LN, Lazar EC, Keenan KP, et al. Recovery and characterization of a coronavirus from military dogs with diarrhea. Proc Annu Meet U S Anim Health Assoc 1974;78:359-66.
23. Pensaert MB, de Bouck P. A new coronavirus-like particle associated with diarrhea in swine, Arch Virol 1978;58: 243-7.
24. Evermann JF, Baumgartener L, Ott RL, et al. Characterization of a feline infectious peritonitis virus isolate. Vet Pathol 1981;18:256-65.
25. Pensaert M, Callebaut P, Vergote J. Isolation of a porcine respiratory, non-enteric coronavirus related to transmissible gastroenteritis. Vet Q 1986;8:257-61.
26. Fouchier RA, Hartwig NG, Bestebroer TM, et al. A previously undescribed coronavirus associated with respiratory disease in humans. Proc Natl Acad Sci USA 2004;101: 6212-6.
27. Herrewegh AA, Vennema H, Horzinek MC, et al. The molecular genetics of feline coronaviruses: comparative sequence analysis of the ORF7a/7b transcription unit of different biotypes. Virology 1995;12:622-31.
28. Haijema BJ, Volders H, Rottier PJ. Live, attenuated coronavirus vaccines through the directed deletion of group-specific genes provide protection against feline infectious peritonitis. J Virol 2004;78:3863-71.
29. Song DS, Yang JS, Oh JS, et al. Differentiation of a Vero cell adapted porcine epidemic diarrhea virus from Korean field strains by restriction fragment length polymorphism analysis of ORF 3. Vaccine 2003;21:1833-42.
30. Woods RD. Efficacy of a transmissible gastroenteritis coronavirus with an altered ORF-3 gene. Can J Vet Res 2001; 65:28-32.
31. Dijkman R, Jebbink MF, Wilbrink B, et al. Human coronavirus 229E encodes a single ORF4 protein between the spike and the envelope genes. Virol J 2006;3:106.
32. Thiel V, Herold J, Schelle B, et al. Infectious RNA transcribed in vitro from a cDNA copy of the human coronavirus genome cloned in vaccinia virus. J Gen Virol 2001; 82:1273-81.
33. Chibo D, Birch C. Analysis of human coronavirus 229E spike and nucleoprotein genes demonstrates genetic drift between chronologically distinct strains. J Gen Virol 2006; 87:1203-8.
34. Pyrc K, Dijkman R, Deng L, et al. Mosaic structure of human coronavirus NL63, one thousand years of evolution. J Mol Biol 2006;364:964-73.
35. Liu C, Feng Y, Gao F, et al. Characterization of HCoV-229E fusion core: implications for structure basis of coronavirus membrane fusion. Biochem Biophys Res Commun 2006; 345:1108-15.
36. Zheng Q, Deng Y, Liu J, et al. Core structure of S2 from the human coronavirus NL63 spike glycoprotein. Biochem 2006;45:15205-15.
37. Pyrc K, Berkhout B, van der Hoek L. Molecular characterization of human coronavirus NL63. In: Recent Research Developments in Infection and Immunity, 3rd edition. Kerala, India: Transworld Research Network, 2005: 25-48.
38. Hofmann H, Simmons G, Rennekamp AJ, et al. Highly conserved regions within the spike proteins of human coronaviruses 229E and NL63 determine recognition of their respective cellular receptors. J Virol 2006;80:8639-52.
39. Lin HX, Feng Y, Wong G, et al. Identification of residues in the receptor-binding domain (RBD) of the spike protein of human coronavirus NL63 that are critical for the RBD-ACE2 receptor interaction. J Gen Virol 2008;89: 1015-24.
40. Bonavia A, Zelus BD, Wentworth DE, et al. Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E. J Virol 2003;77:2530-8.
41. Yeager CL, Ashmun RA, Williams RK, et al. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 1992;357:420-2.
42. Smith MK, Tusell S, Travanty EA, et al. Human angiotensin-converting enzyme 2 (ACE2) is a receptor for human respiratory coronavirus NL63. Adv Exp Med Biol 2006;581:285-8.
43. Hofmann H, Pyrc K, van der Hoek L, et al. Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry. Proc Natl Acad Sci USA 2005;102:7988-93.
44. Kolb AF, Maile J, Heister A, et al. Characterization of functional domains in the human coronavirus HCV 229E receptor. J Gen Virol 1996;77:2515-21.
45. Wang G, Deering C, Macke M, et al. Human coronavirus 229E infects polarized airway epithelia from the apical surface. J Virol 2000;74:9234-9.
46. Mina-Osorio P. The moonlighting enzyme CD13: old and new functions to target. Trends Mol Med 2008;14:361-71.
47. Hamming I, Timens W, Bulthuis ML, et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol 2004;203:631-7.
48. Karamyan VT, Speth RC. Enzymatic pathways of the brain renin-angiotensin system: unsolved problems and continuing challenges. Regul Pept 2007;143:15-27.
49. Oh JS, Song DS, Park BK. Identification of a putative cellular receptor 150 kDa polypeptide for porcine epidemic diarrhea virus in porcine enterocytes. J Vet Sci 2003;4:269-75.
50. Li BX, Ge JW, Li YJ. Porcine aminopeptidase N is a functional receptor for the PEDV coronavirus. Virol 2007;365: 166-72.
51. Delmas B, Gelfi J, L'Haridon R, et al. Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV. Nature 1992;357:417-20.
52. Tresnan DB, Levis R, Holmes KV. Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup I. J Virol 1996;70:8669-74.
53. Li W, Moore MJ, Vasilieva N, et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003;426:450-4.
54. Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med 2005;11:875-9.
55. Lachance C, Arbour N, Cashman NR, et al. Involvement of aminopeptidase N (CD13) in infection of human neural cells by human coronavirus 229E. J Virol 1998;72:6511-9.
56. Freymuth F, Vabret A, Cuvillon-Nimal D, et al. Comparison of multiplex PCR assays and conventional techniques for the diagnostic of respiratory virus infections in children admitted to hospital with an acute respiratory illness. J Med Virol 2006;78:1498-504.
57. Schildgen O, Jebbink MF, de Vries M, et al. Identification of cell lines permissive for human coronavirus NL63. J Virol Methods 2006;138:207-10.
58. Sims AC, Baric RS, Yount B, et al. Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs. J Virol 2005;79:15511-24.
59. Lassnig C, Sanchez CM, Egerbacher M, et al. Development of a transgenic mouse model susceptible to human coronavirus 229E. Proc Natl Acad Sci USA 2005;102: 8275-80.
60. Lassnig C, Kolb A, Strobl B, et al. Studying human pathogens in animal models: fine tuning the humanized mouse. Transgenic Res 2005;14:803-6.
61. Wentworth DE, Tresnan DB, Turner BC, et al. Cells of human aminopeptidase N (CD13) transgenic mice are infected by human coronavirus-229E in vitro, but not in vivo. Virol 2005;335:185-97.
62. Han TH, Chung JY, Kim SW, et al. Human Coronavirus-NL63 infections in Korean children, 2004-2006. J Clin Virol 2007;38:27-31.
63. Arden KE, Nissen MD, Sloots TP, et al. New human coronavirus, HCoV-NL63, associated with severe lower respiratory tract disease in Australia. J Med Virol 2005;75: 455-62.
64. Bastien N, Anderson K, Hart L, et al. Human coronavirus NL63 infection in Canada. J Infect Dis 2005;191:503-6.
65. van Elden LJ, van Loon AM, van Alphen F, et al. Frequent detection of human coronaviruses in clinical specimens from patients with respiratory tract infection by use of a novel real-time reverse-transcriptase polymerase chain reaction. J Infect Dis 2004;189:652-7.
66. Dijkman R, Jebbink MF, EI Idrissi NB, et al. Human coronavirus NL63 and 229E seroconversion in children. J Clin Microbiol 2008;46:2368-73.
67. Shao X, Guo X, Esper F, et al. Seroepidemiology of group I human coronaviruses in children. J Clin Virol 2007;40: 207-13.
68. Gerna G, Percivalle E, Sarasini A, et al. Human respiratory coronavirus HKU1 versus other coronavirus infections in Italian hospitalised patients. J Clin Virol 2007;38:244-50.
69. Vabret A, Dina J, Gouarin S, et al. Human (non-severe acute respiratory syndrome) coronavirus infections in hospitalised children in France. J Paediatr Child Health 2007; 44:176-81.
70. van der Hoek L, Sure K, Ihorst G, et al. Croup is associated with the novel coronavirus NL63. PLoS Med 2005; 2:e240.
71. Callow KA, Parry HF, Sergeant M, et al. The time course of the immune response to experimental coronavirus infection of man. Epidemiol Infect 1990;105:435-46.
72. Bradburne AF, Bynoe ML, Tyrrell DA. Effects of a "new" human respiratory virus in volunteers. Br Med J 1967;3: 767-9.
73. Kapikian AZ, James HD Jr, Kelly SJ, et al. Isolation from man of "avian infectious bronchitis virus-like" viruses (coronaviruses) similar to 229E virus, with some epidemiological observations. J Infect Dis 1969;119:282-90.
74. Wu PS, Chang LY, Berkhout B, et al. Clinical manifestations of human coronavirus NL63 infection in children in Taiwan. Eur J Pediatr 2008;167:75-80.
75. Choi EH, Lee HJ, Kim SJ, et al. The association of newly identified respiratory viruses with lower respiratory tract infections in Korean children, 2000-2005. Clin Infect Dis 2006;43:585-92.
76. Esper F, Shapiro ED, Weibel C, et al. Association between a novel human coronavirus and Kawasaki Disease. J Infect Dis 2005;191:499-502.
77. Burns JC, Glode MP. Kawasaki syndrome. Lancet 2004; 364:533-44.
78. Chang LY, Chiang BL, Kao CL, et al. Lack of association between infection with a novel human coronavirus (HCoV), HCoV-NH, and Kawasaki Disease in Taiwan. J Infect Dis 2006;193:283-6.
79. Dominguez SR, Anderson MS, Glode MP, et al. Blinded case-control study of the relationship between human coronavirus NL63 and Kawasaki syndrome. J Infect Dis 2006;194:1697-701.
80. Baker SC, Shimizu C, Shike H, et al. Human coronavirus-NL63 infection is not associated with acute Kawasaki disease. Adv Exp Med Biol 2006;581:523-6.
81. Shimizu C, Shike H, Baker SC, et al. Human coronavirus NL63 is not detected in the respiratory tracts of children with acute Kawasaki Disease. J Infect Dis 2005;192: 1767-71.
82. Ebihara T, Endo R, Ma X, et al. Lack of association between New Haven coronavirus and Kawasaki disease. J Infect Dis 2005;192:351-2.
83. Burks JS, DeVald BL, Jankovsky LD, et al. Two corona-viruses isolated from central nervous system tissue of two multiple sclerosis patients. Science 1980;209: 933-4.
84. Murray RS, Brown B, Brian D, et al. Detection of coronavirus RNA and antigen in multiple sclerosis brain. Ann Neurol 1992;31:525-33.
85. Arbour N, Day R, Newcombe J, et al. Neuroinvasion by human respiratory coronaviruses. J Virol 2000;74:8913-21.
86. Dessau RB, Lisby G, Frederiksen JL. Coronaviruses in brain tissue from patients with multiple sclerosis. Acta Neuropathol (Berl) 2001;101:601-4.
87. Pyrc K, Bosch BJ, Berkhout B, et al. Inhibition of HCoV-NL63 infection at early stages of the replication cycle. Antim Ag Chemoth 2006;50:2000-8.
88. Cavallaro JJ, Monto AS. Community-wide outbreak of infection with a 229E-like coronavirus in Tecumseh, Michigan. J Infect Dis 1970;122:272-9.
89. Gurcan HM, Ahmed AR. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders. Ann Pharmacother 2007; 41:812-23.
90. Haller O, Weber F. Pathogenic viruses: smart manipulators of the interferon system. Curr Top Microbiol Immunol 2007;316:315-34.
91. Hertzig T, Scandella E, Schelle B, et al. Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA. J Gen Virol 2004;85:1717-25.
92. Tyrrell DA. The efficacy and tolerance of intranasal interferons: studies at the Common Cold Unit. J Antimicrob Chemother 1986;18 Suppl B:153-6.
93. Haasnoot J, Westerhout EM, Berkhout B. RNA interference against viruses: strike and counterstrike. Not Biotechnol 2007;25:1435-43.